Collegium Pharmaceutical Inc (COLL)
EBITDA Margin
35.72%
Quarterly · Period ending:
COLL EBITDA Margin
Latest reported35.72%period ending
Latest reported35.72%period ending
COLL Quarterly EBITDA Margin (0.00% → 35.72%)
Quarterly ebitda margin
High-resolution chart · PNG
COLL ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 35.7183% | |
| 46.5456% | |
| 92.5904% | |
| 58.1336% | |
| 50.0511% | |
| 45.273% | |
| 53.0011% | |
| 47.5333% | |
| 55.1715% | |
| 61.6845% | |
| 67.7512% | |
| 63.4216% | |
| 57.5583% | |
| 29.1178% | |
| 43.1168% | |
| 46.0724% | |
| 39.8805% | |
| 11.4948% | |
| -61.7645% | |
| 39.8209% | |
| 40.5488% | |
| 43.8082% | |
| 42.054% | |
| 46.2501% | |
| 42.986% | |
| 20.6062% | |
| 2.5525% | |
| -2.7597% | |
| -0.8222% | |
| -7.5071% | |
| 37.2152% | |
| 31.2457% | |
| 35.0406% | |
| 26.7549% | |
| -160.0241% | |
| -109.8828% | |
| -589.8034% | |
| -1,052.9466% | |
| -2,093.8603% | |
| -6,413.9706% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |